The levels of
simvastatin and
lovastatin are increased by
clarithromycin, erythromy- cin,
telithromycin and other
macrolides that inhibit CYP3A4 (see macrolides). Rhabdomyolysis has been seen.
It has been recommended that
simvastatin and
lovastatin should be stopped during short courses of these
macrolides.